Antibody-mediated interferences affecting cardiac troponin assays: recommendations from the IFCC Committee on Clinical Applications of Cardiac Biomarkers
Abstract: The International Federation of Clinical Chemistry Committee on Clinical Applications of Cardiac Biomarkers (IFCC C-CB) provides educational documents to facilitate the interpretation and use of cardiac biomarkers in clinical laboratories and practice. Our aim is to improve the understanding of certain key analytical and clinical aspects of cardiac biomarkers and how these may interplay. Measurements of cardiac troponin (cTn) have a prominent place in the clinical work-up of patients with suspected acute coronary syndrome. It is therefore important that clinical laboratories know how to recognize and assess analytical issues. Two emerging analytical issues resulting in falsely high cTn concentrations, often several fold higher than the upper reference limit (URL), are antibody-mediated assay interference due to long-lived cTn-antibody complexes, called macrotroponin, and crosslinking antibodies that are frequently referred to as heterophilic antibodies. We provide an overview of antibody-mediated cTn assay interference and provide recommendations on how to confirm the interference and interpret the results.
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
Antibody-mediated interferences affecting cardiac troponin assays: recommendations from the IFCC Committee on Clinical Applications of Cardiac Biomarkers ; volume:61 ; number:8 ; year:2023 ; pages:1411-1419 ; extent:09
Clinical chemistry and laboratory medicine ; 61, Heft 8 (2023), 1411-1419 (gesamt 09)
- Urheber
-
Hammarsten, Ola
Warner, Janet V.
Lam, Leo
Kavsak, Peter
Lindahl, Bertil
Aakre, Kristin M.
Collinson, Paul
Jaffe, Allan S.
Saenger, Amy K.
Body, Richard
Mills, Nicholas L.
Omland, Torbjørn
Ordonez-Llanos, Jordi
Apple, Fred S.
- DOI
-
10.1515/cclm-2023-0028
- URN
-
urn:nbn:de:101:1-2023070114053664938053
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:54 MESZ
Datenpartner
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Hammarsten, Ola
- Warner, Janet V.
- Lam, Leo
- Kavsak, Peter
- Lindahl, Bertil
- Aakre, Kristin M.
- Collinson, Paul
- Jaffe, Allan S.
- Saenger, Amy K.
- Body, Richard
- Mills, Nicholas L.
- Omland, Torbjørn
- Ordonez-Llanos, Jordi
- Apple, Fred S.
Ähnliche Objekte (12)
High sensitivity cardiac troponin assays
Use of Cardiac Troponin Assays in Hemodialysis Patients
Terminology of cardiac troponin assays and data censoring
Judging the clinical suitability of analytical performance of cardiac troponin assays
Cardiac troponin - friend or foe?
Discovery of novel cardiac troponin activators using fluorescence polarization-based high throughput screening assays
High sensitivity cardiac troponin assays, rapid myocardial infarction rule-out algorithms, and assay performance
The European Biological Variation Study (EuBIVAS): weekly biological variation of cardiac troponin I estimated by the use of two different high-sensitivity cardiac troponin I assays
Cardiac troponin I levels in canine pyometra
Cardiac Troponin I elevation after epileptic seizure
Cardiac Troponin I elevation after epileptic seizure
High incidence of discrepancies in new Siemens assay – a comparison of cardiac troponin I assays
High sensitivity cardiac troponin assays
Use of Cardiac Troponin Assays in Hemodialysis Patients
Terminology of cardiac troponin assays and data censoring
Judging the clinical suitability of analytical performance of cardiac troponin assays
Cardiac troponin - friend or foe?
Discovery of novel cardiac troponin activators using fluorescence polarization-based high throughput screening assays
High sensitivity cardiac troponin assays, rapid myocardial infarction rule-out algorithms, and assay performance
The European Biological Variation Study (EuBIVAS): weekly biological variation of cardiac troponin I estimated by the use of two different high-sensitivity cardiac troponin I assays
Cardiac troponin I levels in canine pyometra
Cardiac Troponin I elevation after epileptic seizure
Cardiac Troponin I elevation after epileptic seizure
High incidence of discrepancies in new Siemens assay – a comparison of cardiac troponin I assays
High sensitivity cardiac troponin assays
Use of Cardiac Troponin Assays in Hemodialysis Patients
Terminology of cardiac troponin assays and data censoring
Judging the clinical suitability of analytical performance of cardiac troponin assays
Cardiac troponin - friend or foe?
Discovery of novel cardiac troponin activators using fluorescence polarization-based high throughput screening assays
High sensitivity cardiac troponin assays, rapid myocardial infarction rule-out algorithms, and assay performance
The European Biological Variation Study (EuBIVAS): weekly biological variation of cardiac troponin I estimated by the use of two different high-sensitivity cardiac troponin I assays
Cardiac troponin I levels in canine pyometra
Cardiac Troponin I elevation after epileptic seizure
Cardiac Troponin I elevation after epileptic seizure